GXMC
ARRY

Global X Management Company’s Array Biopharma Inc ARRY Stock Holding History

Global X Management Company’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$41K Sell
2,433
-1,221
-33% -$19.4K ﹤0.01% 1139
2018
Q1 		$60K Buy
3,654
+918
+34% +$14.7K ﹤0.01% 998
2017
Q4 		$35K Buy
2,736
+621
+29% +$7.06K ﹤0.01% 977
2017
Q3 		$26K Buy
2,115
+304
+17% +$2.82K ﹤0.01% 1021
2017
Q2 		$15K Buy
+1,811
New +$14.8K ﹤0.01% 1192

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Global X Management Company's ARRY Position: Q2 2018 in Review

Global X Management Company reduced its Array Biopharma Inc (ARRY) stake by 33% in Q2 2018, selling an estimated $19.4K and leaving 2,433 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Global X Management Company first reported a position in ARRY in Q2 2017 and has held it in 5 quarters since. The position peaked at $60K in Q1 2018. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Global X Management Company held 2,433 shares of Array Biopharma Inc worth $41K as of Q2 2018.
  • Global X Management Company sold 1,221 Array Biopharma Inc shares in Q2 2018, an estimated $19.4K.
  • Array Biopharma Inc made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1139 holding.
  • Global X Management Company first reported a position in Array Biopharma Inc in Q2 2017 and has held it in 5 quarters since.
  • Global X Management Company's Array Biopharma Inc position peaked at $60K in Q1 2018.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.